<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37326396</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1840-2879</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta medica academica</Title><ISOAbbreviation>Acta Med Acad</ISOAbbreviation></Journal><ArticleTitle>Factors Predictive of In-Hospital Mortality in Patients with Systemic Lupus Erythematosus: A Single-Centre Retrospective Analysis.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>46</EndPage><MedlinePgn>37-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5644/ama2006-124.400</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to investigate the causes and factors predictive of in-hospital death among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care hospital in Thailand.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We retrospectively reviewed the records of patients with SLE admitted between 2017 and 2021. We collected data related to age, sex, body mass index, comorbidities, disease duration, medication usage, clinical symptoms, vital signs, laboratory results, evidence of infection, presence of systemic inflammatory response syndrome, quick sepsis-related organ assessment scores, and SLE disease activity on the date of admission. The length of hospitalization, treatment administered, and subsequent clinical outcomes (including in-hospital complications and death) were also recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 267 enrolled patients, the overall in-hospital mortality rate was 25.5%, and infection was the most common cause of death (75.0%). Multivariate analysis revealed that prior hospitalization within 3 months (odds ratio [OR]: 2.311; 95% confidence interval [CI]: 1.002-5.369; P=0.049), initial infection on admission (OR: 2.764; 95% CI: 1.006-7.594; P=0.048), use of vasopressor drugs (OR: 2.940; 95% CI: 1.071-8.069; P=0.036), and mechanical ventilation (OR: 5.658; 95% CI: 2.046-15.647; P=0.001) were independent risk factors for in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Infection was the major cause of mortality in patients with SLE. Prior hospitalization within 3 months, initial infection on admission, vasopressor use, and mechanical ventilation during admission are independent risk factors for in-hospital mortality in patients with SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Lertwises et al. This article is available under a Creative Commons (Attribution 4.0 International).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lertwises</LastName><ForeName>Sujin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattanasupar</LastName><ForeName>Attapon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Arunchai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand. busmdcu58@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Bosnia and Herzegovina</Country><MedlineTA>Acta Med Acad</MedlineTA><NlmUniqueID>101587903</NlmUniqueID><ISSNLinking>1840-1848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">In-Hospital Death</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Predictor</Keyword><Keyword MajorTopicYN="N">Risk Factor</Keyword><Keyword MajorTopicYN="N">Systemic Lupus Erythematosus</Keyword></KeywordList><CoiStatement><b>Conflict of Interest:</b> The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37326396</ArticleId><ArticleId IdType="pmc">PMC10316072</ArticleId><ArticleId IdType="doi">10.5644/ama2006-124.400</ArticleId><ArticleId IdType="pii">ama2006-124.400</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25(14):1542&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089221</ArticleId><ArticleId IdType="pubmed">27147622</ArticleId></ArticleIdList></Reference><Reference><Citation>Adwan MH, Qasem U, Mustafa KN. In-hospital mortality in patients with systemic lupus erythematosus:a study from Jordan 2002-2017. Rheumatol Int. 2020;40(5):711&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32146489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16868977</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen EY, Shaheen M, Woo JMP, Mercer N, Li N, McCurdy DK, et al. 46-Year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013:A nationwide population-based study. Ann Intern Med. 2017;167(11):777&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188647</ArticleId><ArticleId IdType="pubmed">29086801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jallouli M, Hriz H, Cherif Y, Marzouk S, Snoussi M, Frikha F, et al. Causes and outcome of hospitalisations in Tunisian patients with systemic lupus erythematosus. Lupus Sci Med. 2014;1(1):e000017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225742</ArticleId><ArticleId IdType="pubmed">25396063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa GPD, Ortega MF, Teixeira A, Espinosa G, Cervera R. Causes and factors related to hospitalizations in patients with systemic lupus erythematosus:analysis of a 20-year period (1995-2015) from a single referral centre in Catalonia. Lupus. 2019;28(9):1158&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">31299879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki LT, Feldman CH, Marty FM, Winkelmayer WC, Guan H, Costenbader KH. Serious infection rates among children with systemic lupus erythematosus enrolled in medicaid. Arthritis Care Res. 2017;69(11):1620&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563276</ArticleId><ArticleId IdType="pubmed">28217919</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond WD, Lester S, Preen DB, Keen HI, Inderjeeth CA, Furfaro M, et al. Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014:a longitudinal, population-level, data linkage, cohort study. Lupus Sci Med. 2021;8(1):e000539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527118</ArticleId><ArticleId IdType="pubmed">34667085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikly M, Navarra SV. Lupus in the developing world--is it any different? Best Pract Res Clin Rheumatol. 2008;22(4):643&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18783742</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Torres V, Tar&#xed;n C, Ruiz-Irastorza G, Castej&#xf3;n R, Guti&#xe9;rrez-Rojas &#xc1;, Royuela A, et al. Trends in hospital admissions and death causes in patients with systemic lupus erythematosus:Spanish national registry. J Clin Med. 2021;10(24):5749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8707218</ArticleId><ArticleId IdType="pubmed">34945045</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter EE, Barr SG, Clarke AE. The global burden of SLE:prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016;12(10):605&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27558659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattanaik SS, Muhammed H, Chatterjee R, Naveen R, Lawrence A, Agarwal V, et al. In-hospital mortality and its predictors in a cohort of SLE from Northern India. Lupus. 2020;29(14):1971&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32998621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. Jama. 2017;317(3):290&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">28114553</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribe AG, Vila LM, McGwin G, Jr, Sanchez ML, Reveille JD, Alarcon GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31(10):1934&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15468356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh JH, Park EK, Lee HN, Kim Y, Kim GT, Suh YS, et al. Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea:A multicenter retrospective cohort study. Int J Rheum Dis. 2020;23(1):92&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">31802639</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Torres V, Mart&#xed;nez-Urbistondo M, Guti&#xe9;rrez-Rojas A, Castej&#xf3;n R, S&#xe1;nchez E, Calder&#xf3;n-Parra J, et al. Impact of severe infections in SLE:an observational study from the Spanish national registry. Lupus Sci Med. 2022;9(1):e000711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9608526</ArticleId><ArticleId IdType="pubmed">36283745</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvananda S, Chong YY, Thundyil RJ. Disease activity and damage in hospitalized lupus patients:a Sabah perspective. Lupus. 2020;29(3):344&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">32046576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum. 1995;38(10):1492&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7575699</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss A, Laustrup H, Hjelmborg J, Junker P. Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community. Lupus. 2013;22(11):1185&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerang K, Gilboe IM, Steinar Thelle D, Gran JT. Mortality and years of potential life loss in systemic lupus erythematosus:a population-based cohort study. Lupus. 2014;23(14):1546&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">25209070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Ho LY, Chan KL, Tse SM, To CH. Trend of survival of a cohort of chinese patients with systemic lupus erythematosus over 25 years. Frontiers in medicine. 2020;7:552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516076</ArticleId><ArticleId IdType="pubmed">33015102</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorge A, McCormick N, Lu N, Zheng Y, Esdaile J, De Vera M, et al. Hydroxychloroquine and mortality among patients with systemic lupus erythematosus in the general population. Arthritis Care Res (Hoboken) 2021;73(8):1219&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665987</ArticleId><ArticleId IdType="pubmed">32407570</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripaitoon B, Lertwises S, Uea-Areewongsa P, Khwannimit B. A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit:epidemiology and predictors of mortality. Lupus. 2015;24(1):98&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">25149601</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales-Tisn&#xe9;s T, Quintero-Ortiz L, Quintero-Mu&#xf1;oz E, Sierra-Matamoros F, Arias-Aponte J, Rojas-Villarraga A. Prevalence of hospital readmissions and related factors in patients with autoimmune diseases. J Transl Autoimmun. 2021;4:100121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450261</ArticleId><ArticleId IdType="pubmed">34585131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdany J, Marafino BJ, Dean ML, Bardach NS, Duseja R, Ward MM, et al. Thirty-day hospital readmissions in systemic lupus erythematosus:predictors and hospital- and state-level variation. Arthritis Rheumatol. 2014;66(10):2828&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180780</ArticleId><ArticleId IdType="pubmed">25110993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>